«Nasal Mucosa

Below is an extended Nasal Mucosa patents listing. Click here to return to the Nasal Mucosa main in depth entry.

Patents :
US Patent No.	Title
7342002	Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigen
7361742	Methods and materials for treating inflammatory conditions
7368122	Skin cream
7368426	Methods for the therapeutic use of cyclosporine components
7371755	Antiviral agents
7377901	Apparatus for collection of airway gases
7378078	Compositions and methods for detecting proteolytic activity
7381425	Preservation of bioactive materials by freeze dried foam
7381702	Methods of treating diabetes mellitus
7384640	Mutant cholera holotoxin as an adjuvant
7390505	Nanoparticulate topiramate formulations
7361355	Mutant forms of cholera holotoxin as an adjuvant
7361168	Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
7358222	Preventing airway mucus production by administration of EGF-R antagonists
7344703	Mycobacterial sulfation pathway proteins and methods of use thereof
7347201	Nasal delivery devices
7348360	Method and composition for delivering zinc to the nasal membrane
7351253	Intranasal red light probe for treating Alzheimer's disease
7351542	Methods of modulating tubulin deacetylase activity
7351740	Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
7354894	Preventing airway mucus production by administration of EGF-R antagonists
7354941	Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
7358041	Antibodies to magmas and uses thereof
7358068	Antiviral oligonucleotides
7390619	Optimization of immunomodulatory properties of genetic vaccines
7390788	Peptide pharmaceutical compositions
7407985	Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
7408098	Regulation of quinolate phosphoribosyl transferase expression
7410480	Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
7419497	Methods for treating ethmoid disease
7419971	Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
7423014	Insulin conjugates for treating diabetes mellitus
7423129	Antibodies to human eotaxin
7425217	System and method for inhibiting cellular proliferation with tachykinins
7425445	Modulators that promote cell surface expression of odorant receptors
7425542	Stabilizing alkylglycoside compositions and methods thereof
7407801	Truncated CMV promoters and vectors containing same
7407752	Oligonucleotide complexes for use as anti-viral therapeutics
7405046	Compositions and methods for treatment of rhinovirus
7393924	Smart bio-nanoparticle elements
7396946	Compound for treatment of external secretion disorders
7399477	Cold-adapted equine influenza viruses
7399741	Notch
7399840	Proteosome influenza vaccine
7402566	Peptide inhibitor of TGF-.beta. growth factors
7402591	Analgesic compositions containing buprenorphine
7403805	Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation
7404489	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
7404954	Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor
7425670	Methods and compositions for protein production in tobacco plants with reduced nicotine

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.